不油腻的哒哒哒的个人主页 - 老虎社区

不油腻的哒哒哒

不油腻的哒哒哒

暂无个人介绍

IP属地：未知

4关注

0粉丝

0主题

0勋章

不油腻的哒哒哒

2021-11-30

$老虎证券(TIGR)$今天是不是能加个鸡腿呢

不油腻的哒哒哒

2021-11-27

$老虎证券(TIGR)$打折促销买它

不油腻的哒哒哒

2021-12-07

老乡别走啊

盘前异动：全线反弹！中概股普涨，特斯拉涨超3%

不油腻的哒哒哒

2021-11-26

$拼多多(PDD)$黑五促销

不油腻的哒哒哒

2022-04-07

failure is the mother of success

Aptinyx slides as diabetic pain trial fails to reach main goal

不油腻的哒哒哒

2021-11-30

$洪恩教育(IH)$为啥都没有人在交易呢[微笑]

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4094711751257690","uuid":"4094711751257690","gmtCreate":1631615816828,"gmtModify":1638287815563,"name":"不油腻的哒哒哒","pinyin":"bynddddbuyounidedadada","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/521e89acc5ee91cd53fceb36809286c3","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":4,"tweetSize":6,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.03%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.02.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.04.06","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.04.06","exceedPercentage":"60.18%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":4,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":619521606,"gmtCreate":1649341811621,"gmtModify":1649341811621,"author":{"id":"4094711751257690","authorId":"4094711751257690","name":"不油腻的哒哒哒","avatar":"https://static.tigerbbs.com/521e89acc5ee91cd53fceb36809286c3","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4094711751257690","idStr":"4094711751257690"},"themes":[],"htmlText":"failure is the mother of success","listText":"failure is the mother of success","text":"failure is the mother of success","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/619521606","repostId":"2225263513","repostType":2,"repost":{"id":"2225263513","kind":"news","pubTimestamp":1649338269,"share":"https://www.laohu8.com/m/news/2225263513?lang=&edition=full","pubTime":"2022-04-07 21:31","market":"us","language":"en","title":"Aptinyx slides as diabetic pain trial fails to reach main goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2225263513","media":"seekingalpha","summary":"syahrir maulana/iStock via Getty Images   The shares of clinical-stage biotech, Aptinyx (NASDAQ:APTX","content":"<html><body><p><figure> <picture> <img src=\"https://media.gettyimages.com/photos/diabetic-neuropathy-text-on-sticky-notes-with-office-desk-concept-picture-id1282091481?b=1&amp;k=20&amp;m=1282091481&amp;s=170667a&amp;w=0&amp;h=8-hdaA47vKiB4O_09z6qoNYLdrVgKkkqD5K6qw9J5jA=\"/> </picture> <figcaption><p>syahrir maulana/iStock via Getty Images</p></figcaption> </figure></p> <ul> <li>The shares of clinical-stage biotech, Aptinyx (<span>NASDAQ:APTX</span>) have <span>lost ~53%</span> in the<span> pre-market Thursday after the company announced that its Phase 2b clinical study for NYX-2925 did not reach the primary endpoint in patients with painful diabetic peripheral neuropathy (DPN).</span> </li> <li>The 229-patient randomized, double-blind study did not demonstrate a statistically significant separation from placebo in terms of its primary endpoint, which was the change in pain from baseline measured over 12 weeks using a rating scale, the company said.</li> <li>“We are clearly disappointed that the study did not meet its primary endpoint,” Chief Executive Andy Kidd remarked, adding, “unfortunately, the data from this study do not currently point to a path forward in development for painful DPN.”</li> <li>However, the experimental therapy was well tolerated in the trial with no “concerning safety issues.” according to Aptinyx (APTX).</li> <li>NYX-2925 is currently undergoing a Phase 2b study for fibromyalgia, with data expected in mid-3Q 2022, the company said. </li> </ul></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Aptinyx slides as diabetic pain trial fails to reach main goal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAptinyx slides as diabetic pain trial fails to reach main goal\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-07 21:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3821627-aptx-stock-slides-as-diabetic-pain-trial-fails-to-reach-main-goal><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>syahrir maulana/iStock via Getty Images   The shares of clinical-stage biotech, Aptinyx (NASDAQ:APTX) have lost ~53% in the pre-market Thursday after the company announced that its Phase 2b clinical ...</p>\n\n<a href=\"https://seekingalpha.com/news/3821627-aptx-stock-slides-as-diabetic-pain-trial-fails-to-reach-main-goal\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"APTX":"Aptinyx Inc.","BK4139":"生物科技"},"source_url":"https://seekingalpha.com/news/3821627-aptx-stock-slides-as-diabetic-pain-trial-fails-to-reach-main-goal","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2225263513","content_text":"syahrir maulana/iStock via Getty Images   The shares of clinical-stage biotech, Aptinyx (NASDAQ:APTX) have lost ~53% in the pre-market Thursday after the company announced that its Phase 2b clinical study for NYX-2925 did not reach the primary endpoint in patients with painful diabetic peripheral neuropathy (DPN).  The 229-patient randomized, double-blind study did not demonstrate a statistically significant separation from placebo in terms of its primary endpoint, which was the change in pain from baseline measured over 12 weeks using a rating scale, the company said. “We are clearly disappointed that the study did not meet its primary endpoint,” Chief Executive Andy Kidd remarked, adding, “unfortunately, the data from this study do not currently point to a path forward in development for painful DPN.” However, the experimental therapy was well tolerated in the trial with no “concerning safety issues.” according to Aptinyx (APTX). NYX-2925 is currently undergoing a Phase 2b study for fibromyalgia, with data expected in mid-3Q 2022, the company said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":578,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606642277,"gmtCreate":1638877719507,"gmtModify":1638877719620,"author":{"id":"4094711751257690","authorId":"4094711751257690","name":"不油腻的哒哒哒","avatar":"https://static.tigerbbs.com/521e89acc5ee91cd53fceb36809286c3","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4094711751257690","idStr":"4094711751257690"},"themes":[],"htmlText":"老乡别走啊","listText":"老乡别走啊","text":"老乡别走啊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606642277","repostId":"1189304646","repostType":4,"repost":{"id":"1189304646","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638868683,"share":"https://www.laohu8.com/m/news/1189304646?lang=&edition=full","pubTime":"2021-12-07 17:18","market":"us","language":"zh","title":"盘前异动：全线反弹！中概股普涨，特斯拉涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1189304646","media":"老虎资讯综合","summary":"美股三大指数期货在盘前时段集体上涨。","content":"<p>12月7日（周二），美股三大指数期货在盘前时段集体上涨，道指期货涨幅居前。美国国家过敏症和传染病研究所所长、白宫首席医学顾问安东尼·福奇表示，奥密克戎在毒性方面的初步数据 “令人振奋”。此前来自南非的早期数据表明，该变异毒株可能没有人们担心的那么糟糕。</p>\n<p><img src=\"https://static.tigerbbs.com/c33204cbdbec2a645d17c53468c1b571\" tg-width=\"696\" tg-height=\"243\" referrerpolicy=\"no-referrer\"></p>\n<p><a href=\"https://laohu8.com/S/WB\">微博</a>盘前涨4%。微博即将于明日正式回港二次上市，今日暗盘破发，跌近3%，发行价为272.80港元/股。</p>\n<p>同时，中概股盘前多数走高，<a href=\"https://laohu8.com/S/BABA\">阿里巴巴</a>、<a href=\"https://laohu8.com/S/JD\">京东</a>、<a href=\"https://laohu8.com/S/NTES\">网易</a>、<a href=\"https://laohu8.com/S/BILI\">哔哩哔哩</a>涨超4%，<a href=\"https://laohu8.com/S/PDD\">拼多多</a>涨超5%。</p>\n<p><a href=\"https://laohu8.com/S/INTC\">英特尔</a>盘前涨超7%。据悉，英特尔旗下自动驾驶部门<a href=\"https://laohu8.com/S/MBLY\">Mobileye</a>拟明年独立上市，估值超过500亿美元。</p>\n<p><a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>盘前涨超3%，此前马斯克表示Cybertruck将于2023年开始批量生产。</p>\n<p><a href=\"https://laohu8.com/S/C\">花旗</a>集团盘前涨1.73%，花旗拟出售亚洲众多零售资产，价值高达30亿美元。</p>\n<p><a href=\"https://laohu8.com/S/F\">福特汽车</a>盘前涨1.61%。福特中国高层证实，宁德时代已向福特汽车供货。</p>\n<p><a href=\"https://laohu8.com/S/VIR\">Vir Biotechnology</a>盘前涨超14%。消息面上，葛兰素史克表示其与美国合作伙伴Vir Biotechnology合作开发的新冠抗体药物Xevudy(Sotovimabb)对奥密克戎变种的所有突变均有效。</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>盘前异动：全线反弹！中概股普涨，特斯拉涨超3%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n盘前异动：全线反弹！中概股普涨，特斯拉涨超3%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-12-07 17:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>12月7日（周二），美股三大指数期货在盘前时段集体上涨，道指期货涨幅居前。美国国家过敏症和传染病研究所所长、白宫首席医学顾问安东尼·福奇表示，奥密克戎在毒性方面的初步数据 “令人振奋”。此前来自南非的早期数据表明，该变异毒株可能没有人们担心的那么糟糕。</p>\n<p><img src=\"https://static.tigerbbs.com/c33204cbdbec2a645d17c53468c1b571\" tg-width=\"696\" tg-height=\"243\" referrerpolicy=\"no-referrer\"></p>\n<p><a href=\"https://laohu8.com/S/WB\">微博</a>盘前涨4%。微博即将于明日正式回港二次上市，今日暗盘破发，跌近3%，发行价为272.80港元/股。</p>\n<p>同时，中概股盘前多数走高，<a href=\"https://laohu8.com/S/BABA\">阿里巴巴</a>、<a href=\"https://laohu8.com/S/JD\">京东</a>、<a href=\"https://laohu8.com/S/NTES\">网易</a>、<a href=\"https://laohu8.com/S/BILI\">哔哩哔哩</a>涨超4%，<a href=\"https://laohu8.com/S/PDD\">拼多多</a>涨超5%。</p>\n<p><a href=\"https://laohu8.com/S/INTC\">英特尔</a>盘前涨超7%。据悉，英特尔旗下自动驾驶部门<a href=\"https://laohu8.com/S/MBLY\">Mobileye</a>拟明年独立上市，估值超过500亿美元。</p>\n<p><a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>盘前涨超3%，此前马斯克表示Cybertruck将于2023年开始批量生产。</p>\n<p><a href=\"https://laohu8.com/S/C\">花旗</a>集团盘前涨1.73%，花旗拟出售亚洲众多零售资产，价值高达30亿美元。</p>\n<p><a href=\"https://laohu8.com/S/F\">福特汽车</a>盘前涨1.61%。福特中国高层证实，宁德时代已向福特汽车供货。</p>\n<p><a href=\"https://laohu8.com/S/VIR\">Vir Biotechnology</a>盘前涨超14%。消息面上，葛兰素史克表示其与美国合作伙伴Vir Biotechnology合作开发的新冠抗体药物Xevudy(Sotovimabb)对奥密克戎变种的所有突变均有效。</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/a82005fdd5a20870413111b3adc1a547","relate_stocks":{".DJI":"道琼斯"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189304646","content_text":"12月7日（周二），美股三大指数期货在盘前时段集体上涨，道指期货涨幅居前。美国国家过敏症和传染病研究所所长、白宫首席医学顾问安东尼·福奇表示，奥密克戎在毒性方面的初步数据 “令人振奋”。此前来自南非的早期数据表明，该变异毒株可能没有人们担心的那么糟糕。\n\n微博盘前涨4%。微博即将于明日正式回港二次上市，今日暗盘破发，跌近3%，发行价为272.80港元/股。\n同时，中概股盘前多数走高，阿里巴巴、京东、网易、哔哩哔哩涨超4%，拼多多涨超5%。\n英特尔盘前涨超7%。据悉，英特尔旗下自动驾驶部门Mobileye拟明年独立上市，估值超过500亿美元。\n特斯拉盘前涨超3%，此前马斯克表示Cybertruck将于2023年开始批量生产。\n花旗集团盘前涨1.73%，花旗拟出售亚洲众多零售资产，价值高达30亿美元。\n福特汽车盘前涨1.61%。福特中国高层证实，宁德时代已向福特汽车供货。\nVir Biotechnology盘前涨超14%。消息面上，葛兰素史克表示其与美国合作伙伴Vir Biotechnology合作开发的新冠抗体药物Xevudy(Sotovimabb)对奥密克戎变种的所有突变均有效。","news_type":1},"isVote":1,"tweetType":1,"viewCount":515,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609651537,"gmtCreate":1638282108532,"gmtModify":1638282592324,"author":{"id":"4094711751257690","authorId":"4094711751257690","name":"不油腻的哒哒哒","avatar":"https://static.tigerbbs.com/521e89acc5ee91cd53fceb36809286c3","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4094711751257690","idStr":"4094711751257690"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$老虎证券(TIGR)$</a>今天是不是能加个鸡腿呢","listText":"<a href=\"https://laohu8.com/S/TIGR\">$老虎证券(TIGR)$</a>今天是不是能加个鸡腿呢","text":"$老虎证券(TIGR)$今天是不是能加个鸡腿呢","images":[{"img":"https://static.tigerbbs.com/3a41de35368e245b497a834f1ef47f72","width":"1440","height":"2560"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/609651537","isVote":1,"tweetType":1,"viewCount":844,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":609013977,"gmtCreate":1638214361311,"gmtModify":1638214361378,"author":{"id":"4094711751257690","authorId":"4094711751257690","name":"不油腻的哒哒哒","avatar":"https://static.tigerbbs.com/521e89acc5ee91cd53fceb36809286c3","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4094711751257690","idStr":"4094711751257690"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/IH\">$洪恩教育(IH)$</a>为啥都没有人在交易呢[微笑]&nbsp;","listText":"<a href=\"https://laohu8.com/S/IH\">$洪恩教育(IH)$</a>为啥都没有人在交易呢[微笑]&nbsp;","text":"$洪恩教育(IH)$为啥都没有人在交易呢[微笑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609013977","isVote":1,"tweetType":1,"viewCount":735,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877581268,"gmtCreate":1637942988256,"gmtModify":1637942988256,"author":{"id":"4094711751257690","authorId":"4094711751257690","name":"不油腻的哒哒哒","avatar":"https://static.tigerbbs.com/521e89acc5ee91cd53fceb36809286c3","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4094711751257690","idStr":"4094711751257690"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$老虎证券(TIGR)$</a>打折促销 买它","listText":"<a href=\"https://laohu8.com/S/TIGR\">$老虎证券(TIGR)$</a>打折促销 买它","text":"$老虎证券(TIGR)$打折促销 买它","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877581268","isVote":1,"tweetType":1,"viewCount":785,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877670931,"gmtCreate":1637930267056,"gmtModify":1637930267056,"author":{"id":"4094711751257690","authorId":"4094711751257690","name":"不油腻的哒哒哒","avatar":"https://static.tigerbbs.com/521e89acc5ee91cd53fceb36809286c3","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4094711751257690","idStr":"4094711751257690"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PDD\">$拼多多(PDD)$</a>黑五促销","listText":"<a href=\"https://laohu8.com/S/PDD\">$拼多多(PDD)$</a>黑五促销","text":"$拼多多(PDD)$黑五促销","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877670931","isVote":1,"tweetType":1,"viewCount":667,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":609651537,"gmtCreate":1638282108532,"gmtModify":1638282592324,"author":{"id":"4094711751257690","authorId":"4094711751257690","name":"不油腻的哒哒哒","avatar":"https://static.tigerbbs.com/521e89acc5ee91cd53fceb36809286c3","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094711751257690","authorIdStr":"4094711751257690"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$老虎证券(TIGR)$</a>今天是不是能加个鸡腿呢","listText":"<a href=\"https://laohu8.com/S/TIGR\">$老虎证券(TIGR)$</a>今天是不是能加个鸡腿呢","text":"$老虎证券(TIGR)$今天是不是能加个鸡腿呢","images":[{"img":"https://static.tigerbbs.com/3a41de35368e245b497a834f1ef47f72","width":"1440","height":"2560"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/609651537","isVote":1,"tweetType":1,"viewCount":844,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":877581268,"gmtCreate":1637942988256,"gmtModify":1637942988256,"author":{"id":"4094711751257690","authorId":"4094711751257690","name":"不油腻的哒哒哒","avatar":"https://static.tigerbbs.com/521e89acc5ee91cd53fceb36809286c3","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094711751257690","authorIdStr":"4094711751257690"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$老虎证券(TIGR)$</a>打折促销 买它","listText":"<a href=\"https://laohu8.com/S/TIGR\">$老虎证券(TIGR)$</a>打折促销 买它","text":"$老虎证券(TIGR)$打折促销 买它","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877581268","isVote":1,"tweetType":1,"viewCount":785,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606642277,"gmtCreate":1638877719507,"gmtModify":1638877719620,"author":{"id":"4094711751257690","authorId":"4094711751257690","name":"不油腻的哒哒哒","avatar":"https://static.tigerbbs.com/521e89acc5ee91cd53fceb36809286c3","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094711751257690","authorIdStr":"4094711751257690"},"themes":[],"htmlText":"老乡别走啊","listText":"老乡别走啊","text":"老乡别走啊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606642277","repostId":"1189304646","repostType":4,"repost":{"id":"1189304646","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638868683,"share":"https://www.laohu8.com/m/news/1189304646?lang=&edition=full","pubTime":"2021-12-07 17:18","market":"us","language":"zh","title":"盘前异动：全线反弹！中概股普涨，特斯拉涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1189304646","media":"老虎资讯综合","summary":"美股三大指数期货在盘前时段集体上涨。","content":"<p>12月7日（周二），美股三大指数期货在盘前时段集体上涨，道指期货涨幅居前。美国国家过敏症和传染病研究所所长、白宫首席医学顾问安东尼·福奇表示，奥密克戎在毒性方面的初步数据 “令人振奋”。此前来自南非的早期数据表明，该变异毒株可能没有人们担心的那么糟糕。</p>\n<p><img src=\"https://static.tigerbbs.com/c33204cbdbec2a645d17c53468c1b571\" tg-width=\"696\" tg-height=\"243\" referrerpolicy=\"no-referrer\"></p>\n<p><a href=\"https://laohu8.com/S/WB\">微博</a>盘前涨4%。微博即将于明日正式回港二次上市，今日暗盘破发，跌近3%，发行价为272.80港元/股。</p>\n<p>同时，中概股盘前多数走高，<a href=\"https://laohu8.com/S/BABA\">阿里巴巴</a>、<a href=\"https://laohu8.com/S/JD\">京东</a>、<a href=\"https://laohu8.com/S/NTES\">网易</a>、<a href=\"https://laohu8.com/S/BILI\">哔哩哔哩</a>涨超4%，<a href=\"https://laohu8.com/S/PDD\">拼多多</a>涨超5%。</p>\n<p><a href=\"https://laohu8.com/S/INTC\">英特尔</a>盘前涨超7%。据悉，英特尔旗下自动驾驶部门<a href=\"https://laohu8.com/S/MBLY\">Mobileye</a>拟明年独立上市，估值超过500亿美元。</p>\n<p><a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>盘前涨超3%，此前马斯克表示Cybertruck将于2023年开始批量生产。</p>\n<p><a href=\"https://laohu8.com/S/C\">花旗</a>集团盘前涨1.73%，花旗拟出售亚洲众多零售资产，价值高达30亿美元。</p>\n<p><a href=\"https://laohu8.com/S/F\">福特汽车</a>盘前涨1.61%。福特中国高层证实，宁德时代已向福特汽车供货。</p>\n<p><a href=\"https://laohu8.com/S/VIR\">Vir Biotechnology</a>盘前涨超14%。消息面上，葛兰素史克表示其与美国合作伙伴Vir Biotechnology合作开发的新冠抗体药物Xevudy(Sotovimabb)对奥密克戎变种的所有突变均有效。</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>盘前异动：全线反弹！中概股普涨，特斯拉涨超3%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n盘前异动：全线反弹！中概股普涨，特斯拉涨超3%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-12-07 17:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>12月7日（周二），美股三大指数期货在盘前时段集体上涨，道指期货涨幅居前。美国国家过敏症和传染病研究所所长、白宫首席医学顾问安东尼·福奇表示，奥密克戎在毒性方面的初步数据 “令人振奋”。此前来自南非的早期数据表明，该变异毒株可能没有人们担心的那么糟糕。</p>\n<p><img src=\"https://static.tigerbbs.com/c33204cbdbec2a645d17c53468c1b571\" tg-width=\"696\" tg-height=\"243\" referrerpolicy=\"no-referrer\"></p>\n<p><a href=\"https://laohu8.com/S/WB\">微博</a>盘前涨4%。微博即将于明日正式回港二次上市，今日暗盘破发，跌近3%，发行价为272.80港元/股。</p>\n<p>同时，中概股盘前多数走高，<a href=\"https://laohu8.com/S/BABA\">阿里巴巴</a>、<a href=\"https://laohu8.com/S/JD\">京东</a>、<a href=\"https://laohu8.com/S/NTES\">网易</a>、<a href=\"https://laohu8.com/S/BILI\">哔哩哔哩</a>涨超4%，<a href=\"https://laohu8.com/S/PDD\">拼多多</a>涨超5%。</p>\n<p><a href=\"https://laohu8.com/S/INTC\">英特尔</a>盘前涨超7%。据悉，英特尔旗下自动驾驶部门<a href=\"https://laohu8.com/S/MBLY\">Mobileye</a>拟明年独立上市，估值超过500亿美元。</p>\n<p><a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>盘前涨超3%，此前马斯克表示Cybertruck将于2023年开始批量生产。</p>\n<p><a href=\"https://laohu8.com/S/C\">花旗</a>集团盘前涨1.73%，花旗拟出售亚洲众多零售资产，价值高达30亿美元。</p>\n<p><a href=\"https://laohu8.com/S/F\">福特汽车</a>盘前涨1.61%。福特中国高层证实，宁德时代已向福特汽车供货。</p>\n<p><a href=\"https://laohu8.com/S/VIR\">Vir Biotechnology</a>盘前涨超14%。消息面上，葛兰素史克表示其与美国合作伙伴Vir Biotechnology合作开发的新冠抗体药物Xevudy(Sotovimabb)对奥密克戎变种的所有突变均有效。</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/a82005fdd5a20870413111b3adc1a547","relate_stocks":{".DJI":"道琼斯"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189304646","content_text":"12月7日（周二），美股三大指数期货在盘前时段集体上涨，道指期货涨幅居前。美国国家过敏症和传染病研究所所长、白宫首席医学顾问安东尼·福奇表示，奥密克戎在毒性方面的初步数据 “令人振奋”。此前来自南非的早期数据表明，该变异毒株可能没有人们担心的那么糟糕。\n\n微博盘前涨4%。微博即将于明日正式回港二次上市，今日暗盘破发，跌近3%，发行价为272.80港元/股。\n同时，中概股盘前多数走高，阿里巴巴、京东、网易、哔哩哔哩涨超4%，拼多多涨超5%。\n英特尔盘前涨超7%。据悉，英特尔旗下自动驾驶部门Mobileye拟明年独立上市，估值超过500亿美元。\n特斯拉盘前涨超3%，此前马斯克表示Cybertruck将于2023年开始批量生产。\n花旗集团盘前涨1.73%，花旗拟出售亚洲众多零售资产，价值高达30亿美元。\n福特汽车盘前涨1.61%。福特中国高层证实，宁德时代已向福特汽车供货。\nVir Biotechnology盘前涨超14%。消息面上，葛兰素史克表示其与美国合作伙伴Vir Biotechnology合作开发的新冠抗体药物Xevudy(Sotovimabb)对奥密克戎变种的所有突变均有效。","news_type":1},"isVote":1,"tweetType":1,"viewCount":515,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877670931,"gmtCreate":1637930267056,"gmtModify":1637930267056,"author":{"id":"4094711751257690","authorId":"4094711751257690","name":"不油腻的哒哒哒","avatar":"https://static.tigerbbs.com/521e89acc5ee91cd53fceb36809286c3","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094711751257690","authorIdStr":"4094711751257690"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PDD\">$拼多多(PDD)$</a>黑五促销","listText":"<a href=\"https://laohu8.com/S/PDD\">$拼多多(PDD)$</a>黑五促销","text":"$拼多多(PDD)$黑五促销","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877670931","isVote":1,"tweetType":1,"viewCount":667,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":619521606,"gmtCreate":1649341811621,"gmtModify":1649341811621,"author":{"id":"4094711751257690","authorId":"4094711751257690","name":"不油腻的哒哒哒","avatar":"https://static.tigerbbs.com/521e89acc5ee91cd53fceb36809286c3","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094711751257690","authorIdStr":"4094711751257690"},"themes":[],"htmlText":"failure is the mother of success","listText":"failure is the mother of success","text":"failure is the mother of success","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/619521606","repostId":"2225263513","repostType":2,"repost":{"id":"2225263513","kind":"news","pubTimestamp":1649338269,"share":"https://www.laohu8.com/m/news/2225263513?lang=&edition=full","pubTime":"2022-04-07 21:31","market":"us","language":"en","title":"Aptinyx slides as diabetic pain trial fails to reach main goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2225263513","media":"seekingalpha","summary":"syahrir maulana/iStock via Getty Images   The shares of clinical-stage biotech, Aptinyx (NASDAQ:APTX","content":"<html><body><p><figure> <picture> <img src=\"https://media.gettyimages.com/photos/diabetic-neuropathy-text-on-sticky-notes-with-office-desk-concept-picture-id1282091481?b=1&amp;k=20&amp;m=1282091481&amp;s=170667a&amp;w=0&amp;h=8-hdaA47vKiB4O_09z6qoNYLdrVgKkkqD5K6qw9J5jA=\"/> </picture> <figcaption><p>syahrir maulana/iStock via Getty Images</p></figcaption> </figure></p> <ul> <li>The shares of clinical-stage biotech, Aptinyx (<span>NASDAQ:APTX</span>) have <span>lost ~53%</span> in the<span> pre-market Thursday after the company announced that its Phase 2b clinical study for NYX-2925 did not reach the primary endpoint in patients with painful diabetic peripheral neuropathy (DPN).</span> </li> <li>The 229-patient randomized, double-blind study did not demonstrate a statistically significant separation from placebo in terms of its primary endpoint, which was the change in pain from baseline measured over 12 weeks using a rating scale, the company said.</li> <li>“We are clearly disappointed that the study did not meet its primary endpoint,” Chief Executive Andy Kidd remarked, adding, “unfortunately, the data from this study do not currently point to a path forward in development for painful DPN.”</li> <li>However, the experimental therapy was well tolerated in the trial with no “concerning safety issues.” according to Aptinyx (APTX).</li> <li>NYX-2925 is currently undergoing a Phase 2b study for fibromyalgia, with data expected in mid-3Q 2022, the company said. </li> </ul></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Aptinyx slides as diabetic pain trial fails to reach main goal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAptinyx slides as diabetic pain trial fails to reach main goal\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-07 21:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3821627-aptx-stock-slides-as-diabetic-pain-trial-fails-to-reach-main-goal><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>syahrir maulana/iStock via Getty Images   The shares of clinical-stage biotech, Aptinyx (NASDAQ:APTX) have lost ~53% in the pre-market Thursday after the company announced that its Phase 2b clinical ...</p>\n\n<a href=\"https://seekingalpha.com/news/3821627-aptx-stock-slides-as-diabetic-pain-trial-fails-to-reach-main-goal\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"APTX":"Aptinyx Inc.","BK4139":"生物科技"},"source_url":"https://seekingalpha.com/news/3821627-aptx-stock-slides-as-diabetic-pain-trial-fails-to-reach-main-goal","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2225263513","content_text":"syahrir maulana/iStock via Getty Images   The shares of clinical-stage biotech, Aptinyx (NASDAQ:APTX) have lost ~53% in the pre-market Thursday after the company announced that its Phase 2b clinical study for NYX-2925 did not reach the primary endpoint in patients with painful diabetic peripheral neuropathy (DPN).  The 229-patient randomized, double-blind study did not demonstrate a statistically significant separation from placebo in terms of its primary endpoint, which was the change in pain from baseline measured over 12 weeks using a rating scale, the company said. “We are clearly disappointed that the study did not meet its primary endpoint,” Chief Executive Andy Kidd remarked, adding, “unfortunately, the data from this study do not currently point to a path forward in development for painful DPN.” However, the experimental therapy was well tolerated in the trial with no “concerning safety issues.” according to Aptinyx (APTX). NYX-2925 is currently undergoing a Phase 2b study for fibromyalgia, with data expected in mid-3Q 2022, the company said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":578,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609013977,"gmtCreate":1638214361311,"gmtModify":1638214361378,"author":{"id":"4094711751257690","authorId":"4094711751257690","name":"不油腻的哒哒哒","avatar":"https://static.tigerbbs.com/521e89acc5ee91cd53fceb36809286c3","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094711751257690","authorIdStr":"4094711751257690"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/IH\">$洪恩教育(IH)$</a>为啥都没有人在交易呢[微笑]&nbsp;","listText":"<a href=\"https://laohu8.com/S/IH\">$洪恩教育(IH)$</a>为啥都没有人在交易呢[微笑]&nbsp;","text":"$洪恩教育(IH)$为啥都没有人在交易呢[微笑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609013977","isVote":1,"tweetType":1,"viewCount":735,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}